Antidepressant-related sexual dysfunction - perspectives from neuroimaging.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Sexual dysfunction is a common symptom of major depression and a frequent side-effect of antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs).
• Despite high prescription rates, the underlying neuronal mechanisms of SSRI-related sexual dysfunction remain poorly understood, with limited research available.
• Functional magnetic resonance imaging (fMRI) offers a promising approach to investigate these mechanisms due to the likely involvement of central nervous system processes.

Purpose of the Study:

• To review current clinical findings and neuroimaging correlates of antidepressant-induced sexual dysfunction.
• To link brain regions and networks involved in sexual processing and antidepressant action.
• To highlight fMRI studies on SSRIs (e.g., paroxetine) and serotonin-norepinephrine reuptake inhibitors (SNRIs, e.g., bupropion).

Main Methods:

• Literature review of recent studies on antidepressant-related sexual dysfunction.
• Focus on neuroimaging techniques, primarily fMRI.
• Analysis of clinical findings and their correlation with brain activity patterns.

Main Results:

• SSRIs and SNRIs are associated with sexual dysfunction, impacting various phases of sexual processing.
• fMRI studies reveal alterations in specific brain regions and networks during sexual processing in individuals taking these antidepressants.
• Evidence links central nervous system changes to the manifestation of sexual side effects.

Conclusions:

• Neuroimaging, particularly fMRI, is crucial for elucidating the central mechanisms of SSRI-related sexual dysfunction.
• Understanding these brain correlates can inform the development of strategies to mitigate antidepressant-induced sexual side effects.
• Further research is needed to fully map the neural pathways affected by antidepressants during sexual function.